139 related articles for article (PubMed ID: 16730491)
21. Demographic analysis of post-abortive and interval-administered hormonal contraceptive methods.
Ertopçu K; Inal MM; Ozelmas I
Eur J Contracept Reprod Health Care; 2005 Mar; 10(1):1-5. PubMed ID: 16036290
[TBL] [Abstract][Full Text] [Related]
22. Millions of couples to have choice of injectable contraceptive.
Integration; 1996; (47):41. PubMed ID: 12347310
[TBL] [Abstract][Full Text] [Related]
23. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
Morrison CS; Chen PL; Kwok C; Baeten JM; Brown J; Crook AM; Van Damme L; Delany-Moretlwe S; Francis SC; Friedland BA; Hayes RJ; Heffron R; Kapiga S; Karim QA; Karpoff S; Kaul R; McClelland RS; McCormack S; McGrath N; Myer L; Rees H; van der Straten A; Watson-Jones D; van de Wijgert JH; Stalter R; Low N
PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
Dabee S; Tanko RF; Brown BP; Bunjun R; Balle C; Feng C; Konstantinus IN; Jaumdally SZ; Onono M; Nair G; Palanee-Phillips T; Gill K; Baeten JM; Bekker LG; Passmore JS; Heffron R; Jaspan HB; Happel AU
Front Immunol; 2021; 12():760504. PubMed ID: 34956191
[TBL] [Abstract][Full Text] [Related]
25. Depo-Provera: use of a long-acting progestin injectable contraceptive in Turkish women.
Aktun H; Moroy P; Cakmak P; Yalcin HR; Mollamahmutoglu L; Danisman N
Contraception; 2005 Jul; 72(1):24-7. PubMed ID: 15964288
[TBL] [Abstract][Full Text] [Related]
26. Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
Smit J; McFadyen L; Zuma K; Preston-Whyte E
Soc Sci Med; 2002 Nov; 55(9):1511-22. PubMed ID: 12297238
[TBL] [Abstract][Full Text] [Related]
27. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.
Singata-Madliki M; Smit J; Beksinska M; Balakrishna Y; Avenant C; Beesham I; Seocharan I; Batting J; Hapgood JP; Hofmeyr GJ
PLoS One; 2024; 19(3):e0295764. PubMed ID: 38530848
[TBL] [Abstract][Full Text] [Related]
28. A clinical study of norethisterone enanthate in rural Mexico.
Walther Meade C; Perez Michaud Casarin L; Almazan Diaz M; Guzman Aquado A; Samano Zacarias L; Holck S; Diethelm P; Annus J
Stud Fam Plann; 1984; 15(3):143-8. PubMed ID: 6740731
[TBL] [Abstract][Full Text] [Related]
29. The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health.
Guilbert ER; Brown JP; Kaunitz AM; Wagner MS; Bérubé J; Charbonneau L; Francoeur D; Gilbert A; Gilbert F; Roy G; Senikas V; Jacob R; Morin R
Contraception; 2009 Mar; 79(3):167-77. PubMed ID: 19185668
[TBL] [Abstract][Full Text] [Related]
30. Bone mineral density in women using depot medroxyprogesterone acetate (DMPA) for at least 2 years compared to a control group: a cross sectional study.
Pongsatha S; Ekmahachai M; Chaovisitsaree S; Suntornlimsiri N; Morakote N
J Med Assoc Thai; 2009 Oct; 92(10):1263-7. PubMed ID: 19845231
[TBL] [Abstract][Full Text] [Related]
31. Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Farley TM
S Afr Med J; 2011 Feb; 101(2):131-5. PubMed ID: 21678742
[TBL] [Abstract][Full Text] [Related]
32. When can a woman have repeat progestogen-only injectables--depot medroxyprogesterone acetate or norethisterone enantate?
Paulen ME; Curtis KM
Contraception; 2009 Oct; 80(4):391-408. PubMed ID: 19751863
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetic, biologic and epidemiologic differences in MPA- and NET-based progestin-only injectable contraceptives relative to the potential impact on HIV acquisition in women.
Heffron R; Achilles SL; Dorflinger LJ; Hapgood JP; Kiarie J; Polis CB; Steyn PS
Contraception; 2019 Apr; 99(4):199-204. PubMed ID: 30576636
[TBL] [Abstract][Full Text] [Related]
34. Use of injectable progestin contraception and risk of STI among South African women.
Pettifor A; Delany S; Kleinschmidt I; Miller WC; Atashili J; Rees H
Contraception; 2009 Dec; 80(6):555-60. PubMed ID: 19913149
[TBL] [Abstract][Full Text] [Related]
35. Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.
Beksinska ME; Smit JA; Kleinschmidt I; Milford C; Farley TM
Contraception; 2010 Jan; 81(1):30-4. PubMed ID: 20004270
[TBL] [Abstract][Full Text] [Related]
36. Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers.
Matubu A; Hillier SL; Meyn LA; Stoner KA; Mhlanga F; Mbizvo M; Maramba A; Chirenje ZM; Achilles SL
Am J Reprod Immunol; 2020 Mar; 83(3):e13210. PubMed ID: 31729087
[TBL] [Abstract][Full Text] [Related]
37. Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.
Beksinska ME; Kleinschmidt I; Smit JA; Farley TM; Rees HV
Contraception; 2009 Aug; 80(2):128-32. PubMed ID: 19631787
[TBL] [Abstract][Full Text] [Related]
38. Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.
Beksinska ME; Kleinschmidt I; Smit JA; Farley TM
Contraception; 2009 May; 79(5):345-9. PubMed ID: 19341845
[TBL] [Abstract][Full Text] [Related]
39. Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
Quispe Calla NE; Vicetti Miguel RD; Torres AR; Trout W; Gabriel JM; Hatfield AM; Aceves KM; Kwiek JJ; Kaur B; Cherpes TL
Immunohorizons; 2020 Feb; 4(2):72-81. PubMed ID: 32047094
[TBL] [Abstract][Full Text] [Related]
40. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?
Thurman AR; Hammond N; Brown HE; Roddy ME
J Pediatr Adolesc Gynecol; 2007 Apr; 20(2):61-5. PubMed ID: 17418388
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
